Robert Wild to Obesity
This is a "connection" page, showing publications Robert Wild has written about Obesity.
Connection Strength
1.528
-
Clinical intervention to reduce central obesity and menopausal symptoms in women aged 35 to 55 years. Menopause. 2014 Sep; 21(9):975-81.
Score: 0.301
-
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) and nonHDL particles rise during normal pregnancy and differ by BMI. J Clin Lipidol. 2022 Jul-Aug; 16(4):483-490.
Score: 0.129
-
What Happens After Menopause? (WHAM): A prospective controlled study of cardiovascular and metabolic risk 12 months after premenopausal risk-reducing bilateral salpingo-oophorectomy. Gynecol Oncol. 2021 07; 162(1):88-96.
Score: 0.120
-
Metabolic syndrome in obesity: treatment success and adverse pregnancy outcomes with ovulation induction in polycystic ovary syndrome. Am J Obstet Gynecol. 2021 09; 225(3):280.e1-280.e11.
Score: 0.119
-
Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. J Clin Lipidol. 2021 May-Jun; 15(3):423-430.
Score: 0.119
-
Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome? Fertil Steril. 2020 01; 113(1):87-88.
Score: 0.109
-
It's Absolutely Relative: The Effect of Age on the BMI-Mortality Relationship in Postmenopausal Women. Obesity (Silver Spring). 2020 01; 28(1):171-177.
Score: 0.108
-
Metabolic syndrome and risk of endometrial cancer in postmenopausal women: a prospective study. Cancer Causes Control. 2019 Apr; 30(4):355-363.
Score: 0.103
-
American Society of Clinical Oncology Summit on Addressing Obesity Through Multidisciplinary Provider Collaboration: Key Findings and Recommendations for Action. Obesity (Silver Spring). 2017 11; 25 Suppl 2:S34-S39.
Score: 0.094
-
Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 1995 Jan 16; 98(1A):27S-32S.
Score: 0.077
-
Lipoprotein abnormalities in hirsute women. II. Compensatory responses of insulin resistance and dehydroepiandrosterone sulfate with obesity. Am J Obstet Gynecol. 1992 Dec; 167(6):1813-8.
Score: 0.067
-
Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol. Cancer Med. 2022 02; 11(4):1145-1159.
Score: 0.031
-
Polycystic ovary syndrome: a risk for coronary artery disease? Am J Obstet Gynecol. 2002 Jan; 186(1):35-43.
Score: 0.031
-
Obesity, Height, and Serum Androgen Metabolism among Postmenopausal Women in the Women's Health Initiative Observational Study. Cancer Epidemiol Biomarkers Prev. 2021 11; 30(11):2018-2029.
Score: 0.031
-
The Effects of Reverse Causality and Selective Attrition on the Relationship Between Body Mass Index and Mortality in Postmenopausal Women. Am J Epidemiol. 2019 10 01; 188(10):1838-1848.
Score: 0.027
-
Metabolic aspects of polycystic ovary syndrome. Semin Reprod Endocrinol. 1997 May; 15(2):105-10.
Score: 0.023
-
The gynecologist and the prevention of cardiovascular disease. Am J Obstet Gynecol. 1995 Jan; 172(1 Pt 1):1-13.
Score: 0.019
-
Hyperandrogenism in the adolescent. Obstet Gynecol Clin North Am. 1992 Mar; 19(1):71-89.
Score: 0.016
-
Vulvar acanthosis nigricans: a marker for insulin resistance in hirsute women. Fertil Steril. 1993 Mar; 59(3):583-6.
Score: 0.004